Clinical Trials Directory

Trials / Completed

CompletedNCT01514994

Valvuloplasty Scoring Balloon Catheter First-in-Man Study

Treatment of Critical Aortic Valve Stenosis Using a Novel Valvuloplasty Scoring Balloon Catheter: a First-in-Man Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Spectranetics Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Valvuloplasty Scoring Balloon First-in-Man study is a prospective, single arm, two phase, observational registry to demonstrate the safety and efficacy of the Valvuloplasty Scoring Balloon Catheter for the treatment of critical aortic valve stenosis.

Detailed description

Phase 1 will enroll patient who are scheduled to undergo open surgical aortic valve replacement and will have the Valvuloplasty Scoring Balloon delivered to their stenotic aortic valve through a standard aortotomy and deployed immediately prior to valve replacement. Phase 2 will enroll patients with aortic valve stenosis who are deemed to not be suitable candidates for elective surgical aortic valve replacement and in whom the investigational Valvuloplasty Scoring Balloon will be used as a stand-alone Valvuloplasty procedure or "bridge" to trans-catheter aortic valve implantation (TAVI) or surgery.

Conditions

Interventions

TypeNameDescription
DEVICEAngioScore's Valvuloplasty Scoring BalloonAll patients will receive treatment for their aortic valve stenosis with the Valvuloplasty Scoring Balloon Catheter.

Timeline

Start date
2012-06-01
Primary completion
2014-12-01
Completion
2015-09-01
First posted
2012-01-23
Last updated
2016-04-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01514994. Inclusion in this directory is not an endorsement.